EDIT Earnings

Quarterly EPS
$-0.75
Q3 2024
$-0.55
Q4 2024
$-0.92
Q1 2025
$-0.63
Q2 2025
$-0.28
Q3 2025
$-0.06
Q4 2025
$-0.26
Q1 2026
$-0.15
Q2 2026
Latest Revenue11.9M
Latest Net Income-18230000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.1511.9M-18230000+232.3%+76.2%
Q1 2026-$0.262.8M-24982000-39.2%+71.7%
Q4 2025-$0.0624.7M-5620000-19.2%+89.1%
Q3 2025-$0.287.5M-25117000+12,265.6%+62.7%
Q2 2025-$0.633.6M-53235000+597.5%+23.2%
Q1 2025-$0.924.7M-76088000+310.4%-21.1%
Q4 2024-$0.5530.6M-45395000-49.0%-139.1%
Q3 2024-$0.7561.0K-62141000-98.9%-36.4%
Q2 2024-$0.82513.0K-67607000
Q1 2024-$0.761.1M-61950000
Q4 2023-$0.2360.0M-18874000
Q3 2023-$0.555.3M-45019000
Editas Medicine (EDIT) — Earnings